98%
921
2 minutes
20
Background: An Andersson lesion (AL) is a late-stage lesion of ankylosing spondylitis (AS) that can be misdiagnosed. If the patient has unbearable pain or symptoms indicative of neurological damage, then posterior fusion can be considered. Compared with open surgical procedures, combining Unilateral biportal endoscopy (UBE) and 3D-printing technologies for endoscopic lumbar interbody fusion (LIF) can offer the advantages of minimal trauma and the same effect. In this study, we first used UBE with endoscopic LIF for an AL between T12 and L1 in a 43-year-old male patient with good clinical outcomes.
Methods: A 43-year-old man was admitted to our hospital due to recurrent back pain for 8 years. Based on imaging (computed tomography and radiography) findings, medical history, and clinical examination, we carried out an HLA-B27 blood test to confirm the diagnosis of AS with AL. Finally, we undertook fully endoscopic LIF with UBE based on a 3D-printing model. This patient's pre- and postoperative radiological and clinical results were presented.
Results: Accurate preoperative planning based on a 3D-printing model is strongly recommended for patients with an AL who have ambiguous anatomic landmarks. Applying endoscopic techniques and 3D-printing technologies to the surgical treatment of AL is completely feasible and has an edge in terms of tissue damage.
Conclusion: Endoscopic LIF with UBE based on a 3D-printing model showed a favorable clinical and radiological result and appears to be a safe and effective technique for an AL.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11788314 | PMC |
http://dx.doi.org/10.3389/fsurg.2025.1428072 | DOI Listing |
Spine Surg Relat Res
July 2025
Department of Orthopaedic Surgery, Hokkaido University Hospital, Sapporo, Japan.
Introduction: To compare the clinical outcomes between a full-endoscopic transforaminal approach lumbar interbody fusion (TF-LIF) using the percutaneous endoscopic transforaminal lumbar interbody fusion (PETLIF) system and a minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF).
Methods: A total of 102 patients (80 females, 22 males; mean age: 70.0 years) with degenerative lumbar spine disorders who underwent PETLIF and were followed up for 2 years were assigned to the PETLIF group.
Front Surg
June 2025
Department of Spine Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Objective: This study aimed to evaluate the clinical efficacy and safety of unilateral biportal endoscopic lumbar interbody fusion (UBE-LIF) and posterior lumbar interbody fusion (PLIF) for treating patients with lumbar spinal stenosis with bilateral radiating symptoms. All the patients included in the study had single-segment lumbar spinal stenosis.
Methods: From January 2021 to June 2023, 21 patients with lumbar spinal stenosis treated with UBE-LIF and 29 patients with lumbar spinal stenosis treated with PLIF were retrospectively analyzed.
Exp Ther Med
July 2025
Changzhi Institute of Spinal Disease, Changzhi, Shanxi 046000, P.R. China.
The present study is a retrospective analysis aimed at evaluating the early clinical efficacy and preliminary safety of full-endoscopic transforaminal upper facet joint lumbar interbody fusion (TSAP-LIF) in patients with lumbar degenerative diseases treated at the Department of Orthopaedics at Changzhi Yunfeng Hospital (Changzhi, China). The present study collected clinical follow-up data and radiological images, which were accessed and collected between January 1, 2021 and December 31, 2022. All surgeries were performed by the same group of experienced surgeons to ensure consistency in surgical technique and its impact on patient outcomes.
View Article and Find Full Text PDFWorld Neurosurg
July 2025
Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, China; Department of Spinal Surgery, Northern Jiangsu People's Hospital, Yangzhou, China. Electronic address:
Objective: To compare the clinical outcomes between group A (hybrid endoscopic technique: percutaneous uniportal endoscopic decompression combined with biportal endoscopic lumbar interbody fusion [LIF]) and group B (minimally invasive Quadrant transforaminal LIF) for lumbar spinal stenosis.
Methods: This study included 68 consecutive patients (group A: 32 patients; group B: 36 patients) retrospectively enrolled and treated between June 2019 and June 2021. Perioperative data were prospectively collected, including radiological outcomes (intervertebral disc height, sagittal Cobb angle, lumbar lordosis) and clinical outcomes (Oswestry Disability Index, visual analog scale [VAS], and Short Form 36 Health Survey [SF-36]).
Asian Spine J
April 2025
Spine Division & Head, Orthopaedics Department, School of Medicine, University of Phayao, Phayao, Thailand.
Study Design: A retrospective cohort study.
Purpose: This study aimed to describe the surgical technique of biportal endoscopic (BE) lumbar interbody fusion (LIF) using a multi-layer bone grafting method and to investigate its clinical effectiveness in treating patients with grade I or II lumbar spondylolisthesis (LS).
Overview Of Literature: Previous studies have described BE-LIF; however, these reports predominantly originate from advanced centers in developed countries, using sophisticated implants such as dual transforaminal LIF (TLIF), oblique LIF, or titanium cages.